Blood clotting biotech Hemab hauls in $135M

The latest stories trending on MedCity News.

Editor's Pick

Top Story Blood Clotting Biotech Hemab Hauls In $135M to Drug Rare Bleeding Disorders Hemab Therapeutics will apply its Series B financing toward clinical development of its lead drug candidate, a potential treatment for Glanzmann thrombasthenia. The capital will also support the rest its pipeline addressing rare bleeding and thrombotic diseases with no approved therapies. Sponored Content How to Leverage Diagnostic Development to Guard Against RSV, Flu and Covid-19 Presented by BD and MedCity News A webinar sponsored by BD scheduled for March 7 will explore how diagnostics companies are working with healthcare organizations to guard against the perfect storm of Covid-19, RSV and influenza. Register today!

Featured News

Healthcare is Moving to the Home. Are Health Plans Ready? The future of healthcare means more home-based care. By taking steps now to embrace this shift, health plans will set the pace for supporting patients in the place where they most want to receive care. FDA Approval of Travere Kidney Disease Drug Sets Up Blockbuster Expectations Travere Therapeutics drug Filspari won accelerated FDA approval to treat a rare disorder that can lead to kidney failure. The small molecule is also in late-stage testing for another rare kidney disease; analysts say each indication represents a blockbuster opportunity. Product Innovation: Why End Users Can't Be Afterthoughts in 2023 To drive adoption, digital health solutions must solve real user problems, which means users cannot be an afterthought in developing these solutions. But it's also important to recognize that end users aren't the only group whose needs matter. Workable, scalable digital health solutions must also clear the hurdles of technical feasibility and business viability. Why Blue Shield of California Made Its Wellvolution Platform Available to Medi-Cal Members Blue Shield of California's Wellvolution platform includes programs for mental health, diabetes reversal, addiction and nutrition. Last month, the payer made the platform available to its Medi-Cal members, a process that took two years. Physicians Health Plan of Northern Indiana, Premise Health Partner for Exclusive Primary Care Center Physicians Health Plan of Northern Indiana and Premise Health will build a primary care center in Fort Wayne, Indiana, that will be exclusive to the health plan's fully-insured members in the area. Members will gain access to a care team that comprises physicians, nurse practitioners, a behavioral health specialist and medical assistants.

Resources

How a Top Health Plan Used AI to Achieve a 34% Increase in Cost Savings In this complimentary eBook you will learn how member outreach has been reimagined with AI-powered care management solutions.   Download Now

MedCity News • 611 Broadway • New York, NY unsubscribe